Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
01/18/2021
01/19/2021
01/20/2021
01/21/2021
01/22/2021
Date
31.28
30.49
31.19
32.23
35.45
Last
5450908
5300018
4378173
7278848
13974650
Volume
+1.99% -2.53% +2.30% +3.33% +9.99% Change
Sales 2020
3 282 M 506 M 506 M
Net income 2020
571 M 88,1 M 88,1 M
Net cash position 2020
1 706 M 263 M 263 M
P/E ratio 2020
64,9x
Yield 2020
0,77%
Sales 2021
4 034 M 622 M 622 M
Net income 2021
781 M 121 M 121 M
Net cash position 2021
1 854 M 286 M 286 M
P/E ratio 2021
47,4x
Yield 2021
1,08%
Capitalization
36 461 M 5 625 M 5 626 M
EV / Sales 2020
10,6x
EV / Sales 2021
8,58x
Nbr of Employees
4 270
Free-Float
34,6%
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company distributes its products within domestic market and to overseas markets.
Notations Surperformance© of Shenzhen Salubris Pharmaceuticals Co., Ltd.
Trading Rating : Investor Rating :
All news about SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
News in other languages on SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Chart SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Short Term Mid-Term Long Term Trends Bullish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
5
Average target price
22,60 CNY
Last Close Price
35,45 CNY
Spread / Highest target
-15,4%
Spread / Average Target
-36,2%
Spread / Lowest Target
-58,2%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
